Has Steven Kirtland, MD received payments from drug or device companies?

Yes. Drug and device makers reported $22,342 in general payments to Steven Kirtland, MD across 63 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Steven Kirtland, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Steven Kirtland, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Steven Kirtland, MD

Pulmonary Disease · Seattle, WANPI 1841392842

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (37.4%), travel and lodging and education — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Medtronic at 38.5% of the total. Reporting peaked in 2023 at $9,513 and has fallen 92.6% since, to $700 in 2025. Among pulmonary disease clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$22,342in general payments, 2019–2025

Across 63 payments — averaging $354.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$9K
Intuitive Surgical$6K
Noah Medical Corporation$3K
Verathon Inc.$2K
Johnson & Johnson$1K
Covidien LP$443
plus $575 from 5 others

What the payments were for

Consulting fees$2,0759%
Speaking & faculty fees$8,36037%
Travel & lodging$6,68530%
Food & beverage$2,14210%
Education$3,08014%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic	11	$8,595
Intuitive Surgical	17	$6,289
Noah Medical Corporation	9	$3,039
Verathon Inc.	3	$2,075
Johnson & Johnson	11	$1,327
Covidien LP	2	$443
Pulmonx Corporation	4	$171
Boston Scientific	2	$167
Galvanize Therapeutics, Inc	1	$98
Genentech USA, Inc.	2	$80
Auris Health, Inc.	1	$59

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$22,342 in reported general payments places this provider in the 90th percentile of 275 pulmonary disease providers in Washington.

See all pulmonary disease providers in Washington →

Medicare billing

Part B allowed, 2024

$209,472

Medicare patients

510

Services billed

1,878

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
OfevNintedanib Esylate	23	$297,884
Trelegy ElliptaFluticasone/Umeclidin/Vilanter	83	$90,262
Breztri AerosphereBudesonide/Glycopyr/Formoterol	76	$87,520
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr	81	$57,109
Stiolto RespimatTiotropium Br/Olodaterol Hcl	60	$43,676
EliquisApixaban	45	$36,494
Spiriva RespimatTiotropium Bromide	44	$31,755
Incruse ElliptaUmeclidinium Bromide	45	$28,606
Spiriva HandihalerTiotropium Bromide	15	$15,502
Fluticasone-SalmeterolFluticasone Propion/Salmeterol	42	$13,568
SymbicortBudesonide/Formoterol Fumarate	38	$12,670
Breo ElliptaFluticasone/Vilanterol	22	$11,142
Advair HfaFluticasone Propion/Salmeterol	16	$10,857
Arnuity ElliptaFluticasone Furoate	14	$6,775
DuleraMometasone/Formoterol	14	$6,649

Paid to pharmacies, not to this prescriber.

Other pulmonary disease in Seattle

Jed GordenSeattle$236K
Oneil BainsSeattle$156K
Ganesh RaghuSeattle$147K
Jeffrey CarySeattle$106K
Amy DickeySeattle$71K
Lawrence HoSeattle$70K
Christopher GossSeattle$44K
Reena MehraSeattle$36K
Rebecca SellSeattle$30K
Peter LearySeattle$27K

See the full list for Washington →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →